Cargando…

Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors

BACKGROUND: Paclitaxel is one of the most commonly used drugs to treat breast cancer. Its major dose-limiting toxicity is paclitaxel-induced peripheral neuropathy (PIPN). PIPN persists into survivorship and has a negative impact on patient’s mood, functional status, and quality of life. No intervent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kober, Kord M, Olshen, Adam, Conley, Yvettte P, Schumacher, Mark, Topp, Kimberly, Smoot, Betty, Mazor, Melissa, Chesney, Margaret, Hammer, Marilyn, Paul, Steven M, Levine, Jon D, Miaskowski, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293373/ https://www.ncbi.nlm.nih.gov/pubmed/30426838 http://dx.doi.org/10.1177/1744806918816462

Ejemplares similares

Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors
por: Miaskowski, Christine, et al.
Publicado: (2019)

Signaling pathways and gene co-expression modules associated with cytoskeleton and axon morphology in breast cancer survivors with chronic paclitaxel-induced peripheral neuropathy
por: Kober, Kord M, et al.
Publicado: (2019)

Differential methylation and expression of genes in the hypoxia-inducible factor 1 signaling pathway are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors and with preclinical models of chemotherapy-induced neuropathic pain
por: Kober, Kord M, et al.
Publicado: (2020)

Higher levels of stress and different coping strategies are associated with greater morning and evening fatigue severity in oncology patients receiving chemotherapy
por: Wright, Fay, et al.
Publicado: (2020)

Perturbations in common and distinct inflammatory pathways associated with morning and evening fatigue in outpatients receiving chemotherapy
por: Kober, Kord M., et al.
Publicado: (2022)

Anxiety in oncology outpatients is associated with perturbations in pathways identified in anxiety focused network pharmacology research
por: Oppegaard, Kate, et al.
Publicado: (2023)

Network Analysis of the Multidimensional Symptom Experience of Oncology
por: Papachristou, Nikolaos, et al.
Publicado: (2019)

Torch-eCpG: A fast and scalable eQTM mapper for thousands of molecular phenotypes with graphical processing units
por: Kober, Kord M., et al.
Publicado: (2023)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
por: Klein, Ines, et al.
Publicado: (2021)

Network analysis to identify symptoms clusters and temporal interconnections in oncology patients
por: Kalantari, Elaheh, et al.
Publicado: (2022)

Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats
por: Mansooralavi, Niloufar, et al.
Publicado: (2023)

Associations among hearing loss, multiple co-occurring symptoms, and quality of life outcomes in cancer survivors
por: Miaskowski, Christine, et al.
Publicado: (2022)

Learning from data to predict future symptoms of oncology patients
por: Papachristou, Nikolaos, et al.
Publicado: (2018)

Systematic review of the effectiveness of self-initiated interventions to decrease pain and sensory disturbances associated with peripheral neuropathy
por: Ogle, Theodora, et al.
Publicado: (2020)

The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathy
por: Sato, Junya, et al.
Publicado: (2016)

2043: Pharmacokinetic prediction of paclitaxel-induced peripheral neuropathy
por: Hertz, Daniel L., et al.
Publicado: (2018)

Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan
por: Hiramoto, Shiori, et al.
Publicado: (2021)

Peripheral Neuropathy Caused by Paclitaxel and Docetaxel: An Evaluation and Comparison of Symptoms
por: Tofthagen*, Cindy, et al.
Publicado: (2013)

Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic
por: Miaskowski, Christine, et al.
Publicado: (2020)

Distinct employment interference profiles in patients with breast cancer prior to and for 12 months following surgery
por: Chan, Raymond Javan, et al.
Publicado: (2021)

Berberine Alleviates Paclitaxel-Induced Neuropathy
por: Rezaee, Ramin, et al.
Publicado: (2019)

Effect of certain trimethoxy flavones on paclitaxel - induced peripheral neuropathy in mice
por: Nadipelly, Jagan, et al.
Publicado: (2018)

Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
por: Ghoreishi, Zohreh, et al.
Publicado: (2018)

Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy
por: Chen, Yi-Fan, et al.
Publicado: (2017)

Losartan attenuates neuroinflammation and neuropathic pain in paclitaxel‐induced peripheral neuropathy
por: Kalynovska, Nataliia, et al.
Publicado: (2020)

A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice
por: Caillaud, Martial, et al.
Publicado: (2020)

Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
por: Kawashiri, Takehiro, et al.
Publicado: (2021)

Discovery of Potential Neuroprotective Agents against Paclitaxel-Induced Peripheral Neuropathy
por: Chen, Yi-Fan, et al.
Publicado: (2022)

Upper extremity impairments in women with or without lymphedema following breast cancer treatment
por: Smoot, Betty, et al.
Publicado: (2010)

A fruit fly model for studying paclitaxel-induced peripheral neuropathy and hyperalgesia
por: Hamoudi, Zina, et al.
Publicado: (2018)

Acupuncture for Paclitaxel-Induced Peripheral Neuropathy: A Review of Clinical and Basic Studies
por: Zhao, Yu-Xue, et al.
Publicado: (2021)

Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy
por: Griffiths, Lisa A., et al.
Publicado: (2015)

Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy
por: LoCoco, Peter M, et al.
Publicado: (2017)

Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy
por: Brazill, Jennifer M., et al.
Publicado: (2018)

A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral Neuropathy
por: Leen, Alisha Joan, et al.
Publicado: (2022)

Longitudinal RNA Sequencing of Skin and DRG Neurons in Mice with Paclitaxel-Induced Peripheral Neuropathy
por: Cirrincione, Anthony M., et al.
Publicado: (2022)

Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study
por: Hooshmand, Kosar, et al.
Publicado: (2022)

New Treatment for the Cognitive and Emotional Deficits Linked with Paclitaxel-Induced Peripheral Neuropathy in Mice
por: Martínez-Martel, Ignacio, et al.
Publicado: (2022)

Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221
por: Chen, Ciao-Sin, et al.
Publicado: (2023)

Self-Management of Oxaliplatin-Related Peripheral Neuropathy in Colorectal Cancer Survivors
por: Tofthagen, Cindy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_snmbifjk2qr2b3iab6p6h51cg7